Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 2

Status

Completed 38Recruiting 32Active not recruiting 15Terminated 13Withdrawn 8Unknown 7Not yet recruiting 3Suspended 2

Sponsor Class

OTHER 5OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Gastrointestinal 17Dermatologic 10Thoracic 8Breast 7Head & Neck 5Gynecologic 5Genitourinary 5Other hematologic neoplasm 3Sarcoma 2NET 2Lymphoid 2Endocrine 2Tumor-Agnostic 1Other neoplasm 1Myeloid 1

Conditions

Breast Neoplasms 5Breast Neoplasms, Male 2Triple Negative Breast Neoplasms 1HER2-positive Breast Cancer 1Esophageal Neoplasms 1

Interventions

Cyclophosphamide 89Capecitabine 88Trastuzumab 81Docetaxel 81Paclitaxel 65Epirubicin 57pyrotinib 55Tamoxifen 54Letrozole 53Fulvestrant 49Vinorelbine 43Carboplatin 43Doxorubicin 41Radiotherapy 33Anastrozole 32exemestane 31Neoadjuvant Therapy 29palbociclib 27Drug Therapy 27Fluorouracil 24Bevacizumab 24pertuzumab 23Cisplatin 23eribulin 22Exercise 21130-nm albumin-bound paclitaxel 21Goserelin 20Gemcitabine 20Chemotherapy, Adjuvant 19Albumin-Bound Paclitaxel 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Unknown × Biopsy × Breast × Clear all
NCT05703295 2023-01-30

Oncologic Safety of Sentinel Lymph Node Biopsy in Clinically Palpable Axillary Lymph Node in Breast Cancer Patients

Assiut University

Unknown
40 enrolled
Breast

Breast Neoplasms

NCT05619016 2022-11-30

[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors

Karolinska University Hospital

Phase 2 Unknown
72 enrolled
BreastGastrointestinal

Breast Neoplasms, Esophageal Neoplasms

NCT04288141 2022-11-14

HERdi PREDICT

King's College London

Unknown
40 enrolled
Breast

HER2-positive Breast Cancer

NCT04758416 2022-04-20

Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer

Fudan University

Unknown
50 enrolled
Breast

Breast Neoplasms

NCT03706534 2019-10-29

Breast Ultrasound Image Reviewed With Assistance of Deep Learning Algorithms

Samsung Medison

Phase NA Unknown
300 enrolled
Breast

Breast Neoplasms

NCT01372579 2019-06-07

Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients

Northwestern University

Phase 2 Unknown
30 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms

NCT02480933 2017-11-28

SISYPHUS

Centro Hospitalar Lisboa Ocidental

Phase NA Unknown
768 enrolled
Breast

Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡